/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Atypical flutter: effectiveness of a systematic strategy based on comprehensive high-density map analysis
Event: ESC Congress 2023
Topic: Catheter Ablation of Arrhythmias
Session: Update on EP studies, anti-arrhythmic drugs, and ablation techniques
Biatrial flutters: unique circuits requiring a customized ablation approach
Event: ESC Congress 2023
Topic: Treatment
Session: Novel prognostic, mapping, and ablation technologies for supraventricular tachycardia
Is there still a role for neurohormonal therapy in patients with STEMI and mildly reduced ejection
Event: Heart Failure 2023
Topic: Heart Failure with Mid-Range Ejection Fraction (HFmrEF)
Session: ePosters in chronic heart failure - pathophysiology and mechanisms 4
Levosimendan - single center experience in chronic HF
Event: Heart Failure 2023
Topic: Pharmacotherapy
Session: ePosters in chronic heart failure - pharmacotherapy 4
Sodium-glucose cotransporter 2 inhibitors in patients with transthyretin amyloid cardiomyopathy - results from a patient series
Event: Heart Failure 2023
Topic: Pharmacotherapy
Session: Chronic heart failure - pharmacotherapy 5
Late potentials assessment - an useful tool for Brugada Syndrome risk stratification
Event: EHRA 2023
Topic: Signal-Averaged Electrocardiography
Session: Young Investigator Award - Clinical
Spontaneous left-sided atypical flutter: revising the mechanisms in patients not submitted to prior linear ablation
Event: EHRA 2023
Topic: Treatment
Session: ePoster session 3
Brugada syndrome in Portugal: a cohort characterization
Event: ESC Congress 2022
Topic: Ion Channel Disorders
Session: Long-term follow-up of patients with primary electrical disease
SGLT2 inhibition in acute myocardial infarction with left ventricular systolic dysfunction
Event: Heart Failure 2022
Topic: Treatment
Session: Heart Failure ePosters - focus on CAD / CSS / ACS / ACC
Main limiting factors of foundational therapy introduction in patients with heart failure with reduced ejection fraction
Event: Heart Failure 2022
Topic: Pharmacotherapy
Session: Heart Failure ePosters - focus on Chronic Heart Failure 1
ESC 365 is supported by
